Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jin Q Cheng

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
The Journal of Biological Chemistry|March 21, 2008
Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic functionGeorge Z Cheng, Wei Zhou Zhang, Mei Sun, et al.
Oncogene|January 26, 2016
Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancerYajuan Li, Mattia Lauriola, Donghwa Kim, et al.
The Journal of Biological Chemistry|June 6, 2002
Inhibition of JNK by cellular stress- and tumor necrosis factor alpha-induced AKT2 through activation of the NF kappa B pathway in human epithelial CellsZeng-qiang Yuan, Richard I Feldman, Mei Sun, et al.
Frontiers in Bioscience : a Journal and Virtual Library|December 1, 2004
AKT/PKB signaling mechanisms in cancer and chemoresistanceDonghwa Kim, Han C Dan, Sungman Park, et al.
Cancer Research|January 18, 2008
MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTENHua Yang, William Kong, Lili He, et al.
Cancer Research|June 12, 2016
IKBKE Is a Substrate of EGFR and a Therapeutic Target in Non-Small Cell Lung Cancer with Activating Mutations of EGFRSridevi Challa, Jian-Ping Guo, Xiaowen Ding, et al.
Oncogene|July 12, 2005
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathwaysQing Xu, Jon Briggs, Sungman Park, et al.
The Journal of Biological Chemistry|February 3, 2005
Molecular and genetic studies imply Akt-mediated signaling promotes protein kinase CbetaII alternative splicing via phosphorylation of serine/arginine-rich splicing factor SRp40Niketa A Patel, Satoshi Kaneko, Hercules S Apostolatos, et al.
Anticancer Research|February 16, 2006
Ascorbyl stearate inhibits cell proliferation and tumor growth in human ovarian carcinoma cells by targeting the PI3K/AKT pathwayQuan Fang, K Akhilender Naidu, Kamatham A Naidu, et al.
Investigational New Drugs|July 21, 2010
Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors containing activated AKTChristopher R Garrett, Domenico Coppola, Robert M Wenham, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
The Journal of Biological Chemistry|March 21, 2008
Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic functionGeorge Z Cheng, Wei Zhou Zhang, Mei Sun, et al.
Oncogene|January 26, 2016
Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancerYajuan Li, Mattia Lauriola, Donghwa Kim, et al.
The Journal of Biological Chemistry|June 6, 2002
Inhibition of JNK by cellular stress- and tumor necrosis factor alpha-induced AKT2 through activation of the NF kappa B pathway in human epithelial CellsZeng-qiang Yuan, Richard I Feldman, Mei Sun, et al.
Frontiers in Bioscience : a Journal and Virtual Library|December 1, 2004
AKT/PKB signaling mechanisms in cancer and chemoresistanceDonghwa Kim, Han C Dan, Sungman Park, et al.
Cancer Research|January 18, 2008
MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTENHua Yang, William Kong, Lili He, et al.
Cancer Research|June 12, 2016
IKBKE Is a Substrate of EGFR and a Therapeutic Target in Non-Small Cell Lung Cancer with Activating Mutations of EGFRSridevi Challa, Jian-Ping Guo, Xiaowen Ding, et al.
Oncogene|July 12, 2005
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathwaysQing Xu, Jon Briggs, Sungman Park, et al.
The Journal of Biological Chemistry|February 3, 2005
Molecular and genetic studies imply Akt-mediated signaling promotes protein kinase CbetaII alternative splicing via phosphorylation of serine/arginine-rich splicing factor SRp40Niketa A Patel, Satoshi Kaneko, Hercules S Apostolatos, et al.
Anticancer Research|February 16, 2006
Ascorbyl stearate inhibits cell proliferation and tumor growth in human ovarian carcinoma cells by targeting the PI3K/AKT pathwayQuan Fang, K Akhilender Naidu, Kamatham A Naidu, et al.
Investigational New Drugs|July 21, 2010
Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors containing activated AKTChristopher R Garrett, Domenico Coppola, Robert M Wenham, et al.
Pageof 12